Bioxytran, Inc (BIXT): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2016-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$11.1K
As of 2016-12-31
-18.8%
3-year compound annual growth
-7.7%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2016-12-31 | $11.1K | +218.6% | 2017-03-31, Balance as of period end |
| 2015-12-31 | $3.5K | -43.6% | 2017-03-31, Balance as of period end |
| 2014-12-31 | $6.2K | -70.2% | 2016-09-20, Balance as of period end |
| 2013-12-31 | $20.7K | +274.6% | 2015-04-10, Balance as of period end |
| 2012-12-31 | $5.5K | -66.6% | 2014-04-14, Balance as of period end |
| 2011-12-31 | $16.5K | -27.4% | 2013-04-15, Balance as of period end |
| 2010-12-31 | $22.8K | +297.3% | 2012-12-31, Balance as of period end |
| 2009-12-31 | $5.7K | n/a | 2012-12-31, Balance as of period end |